NON-SQUAMOUS NON-SMALL CELL LUNG CANCER
Clinical trials for NON-SQUAMOUS NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new NON-SQUAMOUS NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for NON-SQUAMOUS NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Early cancer drug trial halted after testing in just 3 patients
Disease control TerminatedThis was a very early, first-in-human study to test the safety and find the right dose of an experimental drug called AMG 794. It was for adults with advanced or spreading cancers that have a specific marker called Claudin 6 (CLDN6), including certain lung and ovarian cancers. Th…
Matched conditions: NON-SQUAMOUS NON-SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: Amgen • Aim: Disease control
Last updated Apr 01, 2026 14:40 UTC
-
Experimental drug tested for Tough-to-Treat cancers
Disease control TerminatedThis study tested an experimental drug called VLS-101 (zilovertamab vedotin) in 102 people with advanced solid tumors that had spread and stopped responding to previous treatments. The trial aimed to see if the drug could shrink tumors and was safe for cancers including breast, l…
Matched conditions: NON-SQUAMOUS NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: VelosBio Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Terminated trial tests triple attack on lung cancer
Disease control TerminatedThis study tested whether adding two experimental drugs (SHR-1210 and famitinib) to standard chemotherapy could better control advanced non-squamous lung cancer. It enrolled 48 adults who had not yet received chemotherapy for their advanced cancer. The trial was terminated early,…
Matched conditions: NON-SQUAMOUS NON-SMALL CELL LUNG CANCER
Phase: PHASE3 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC